ViroCyt Appoints Greg Krueger to Lead Global Sales
BOULDER, CO–(Marketwired – July 28, 2015) – ViroCyt, the leader in rapid virus quantification, announced today that Greg Krueger has joined the team as Vice President of Global Sales.
Greg brings over 20 years of experience in the commercialization of life science products, including sales, marketing and business development roles at Sartorius Stedim Biotech, Becton Dickinson, Accuri Cytometers, GE Healthcare, Pharmacia and Amersham. He obtained his undergraduate and graduate education in science at the University of Wisconsin in Madison, as well as a Masters of Business Administration at the Keller School of Management.
Said Robert Kline, President and CEO of ViroCyt, “We are excited to have Greg join the ViroCyt team. He brings a wealth of experience and contacts within our targeted markets. As our business continues to scale, Greg will be adding to and directing our domestic and international channel resources.”
“The opportunity to work with such an experienced and focused group is truly exciting,” stated Greg Krueger. “I look forward to continuing to meet the impressive global demand for ViroCyt’s innovative technologies, which are being used to save time and money bringing life-saving vaccines and therapies to the marketplace.”
About ViroCyt, Inc.
ViroCyt, Inc. was created with the goal of bringing game-changing solutions to the Life Science industry. Our primary focus is replacing outdated technologies that slow down the pace of virus-related research and product development. Additional information can be found at http://www.virocyt.com.
Vice President, Marketing & Strategic Partnering
Source: ViroCyt, Inc.